CureVac to Present at the 8th Annual Leerink Partners Global Healthcare Conference

TÜBINGEN, Germany / BOSTON, MA, February 19, 2019 – CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichella, Chief Executive Officer, will present a corporate overview at the 8th Annual Leerink Partners Global Healthcare Conference in New York on Wednesday, February 27, 2019 at 1:50 p.m. ET.

A live broadcast of the presentation will be available at www.curevac.com/en/newsroom/curevacevents.  An archived replay of the presentation will be available on the company’s website for approximately 3 months following the presentation.

Download press release as PDF file.